Annelien J.M. Zweemer

Functionally biased modulation of A3 adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers

Zhan‐Guo Gao, Dennis Verzijl, Annelien J.M. Zweemer et al. · Biochemical Pharmacology · 2011 · 71 citations

Signal Transduction, Biochemistry, Functional Selectivity +8

False Positives in a Reporter Gene Assay: Identification and Synthesis of Substituted <i>N</i>-Pyridin-2-ylbenzamides as Competitive Inhibitors of Firefly Luciferase

Laura H. Heitman, Jacobus P. D. van Veldhoven, Annelien J.M. Zweemer et al. · Journal of Medicinal Chemistry · 2008 · 65 citations · Full text

Drug Target, Firefly Luciferase, Molecular Biology +20

Multiple Binding Sites for Small-Molecule Antagonists at the CC Chemokine Receptor 2

Annelien J.M. Zweemer, Indira Nederpelt, Hilde Vrieling et al. · Molecular Pharmacology · 2013 · 65 citations

Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies

Dana Faratian, Annelien J.M. Zweemer, Yoko Nagumo et al. · Clinical Cancer Research · 2011 · 63 citations · Full text

A Series of 2,4-Disubstituted Quinolines as a New Class of Allosteric Enhancers of the Adenosine A₃Receptor

Laura H. Heitman, Anikó Göblyös, Annelien J.M. Zweemer et al. · Journal of Medicinal Chemistry · 2009 · 62 citations · Full text